TRV GP IV, LLC Long-Term Concentrated

CIK: 0001688325 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $235,167 (100.0% shares, 0.0% debt)

Holdings (5)

TNGX TANGO THERAPEUTICS, INC. 59.7%

Value ($000) $140,389 Shares 19,363,975 Est. Cost $11.99 Unrealized -41.3%

PLRX PLIANT THERAPEUTICS, INC. 17.5%

Value ($000) $41,228 Shares 2,132,867 Est. Cost $26.54 Unrealized -21.2%

RVMD REVOLUTION MEDICINES, INC. 14.4%

Value ($000) $33,822 Shares 1,419,900 Est. Cost $27.68 Unrealized -23.2%

FULC FULCRUM THERAPEUTICS, INC. 7.3%

Value ($000) $17,058 Shares 2,343,154 Est. Cost $11.06 Unrealized -41.1%

— MAGENTA THERAPEUTICS, INC. 1.1%

Value ($000) $2,669 Shares 6,758,204 Est. Cost $5.70 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
TNGX	TANGO THERAPEUTICS, INC.	19,363,975	$140,389	59.7%	$11.99	-41.3%	COM	87583X109
PLRX	PLIANT THERAPEUTICS, INC.	2,132,867	$41,228	17.5%	$26.54	-21.2%	COM	729139105
RVMD	REVOLUTION MEDICINES, INC.	1,419,900	$33,822	14.4%	$27.68	-23.2%	COM	76155X100
FULC	FULCRUM THERAPEUTICS, INC.	2,343,154	$17,058	7.3%	$11.06	-41.1%	COM	359616109
—	MAGENTA THERAPEUTICS, INC.	6,758,204	$2,669	1.1%	$5.70	—	COM	55910K108